MDxHealth Maintains Its Previously Issued 2024 Revenue Guidance Of $79M-$81M (Est $79.629M); Confirms Its View Of Expected Adjusted EBITDA Profitability In H1'2025
MDxHealth维持其先前发布的2024年7900万至8100万美元(约合7,9629万美元)的收入指导;证实了其对2025年上半年预期调整后息税折旧摊销前利润盈利能力的看法